Radiation therapy for colorectal cancer
Doctors use different types of radiation therapy to treat both rectal and colon cancer. Being treated with chemotherapy at the same time can make radiation therapy more effective for some colorectal cancers.
Doctors use different types of radiation therapy to treat both rectal and colon cancer. Being treated with chemotherapy at the same time can make radiation therapy more effective for some colorectal cancers.
Radiation therapy is a form of cancer treatment that uses high-energy rays to destroy cancer cells. The cells in your body normally grow and divide to form new cells. Cancer cells grow and divide faster than normal cells, which can create tumors. Radiation damages the DNA inside cells. When the cells are damaged, they stop growing and dividing and eventually die.
Radiation therapy is a common treatment for rectal cancer. It is used either before or after surgery, and usually along with chemotherapy.
It may be used prior to surgery (neoadjuvant therapy) to shrink a tumor to make it easier to remove, or afterwards to destroy cancer cells that cannot be removed with surgery.
Rectal tumors that come back in the pelvis after radiation therapy may be re-treated with radiation.
Radiation therapy may also be used to ease symptoms of advanced rectal cancer such as pain, bleeding, or intestinal obstructions.
Talk with your doctor about the possible side effects of your radiation therapy regimen before your treatment begins so you know what to expect. Most side effects go away soon after treatment is finished, but some may not go away completely. Ask your doctor about any lasting side effects.
Possible side effects from radiation therapy for colorectal cancer may include:
If you are planning to have a child, talk to your doctor before treatment begins about your options for preserving fertility.
The treatment option is for patients with KRASG12C-mutated locally advanced or metastatic colorectal cancer (CRC) who have received prior treatment with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy.
Statistics suggested that Christy’s odds of survival were grim, so she leaned into her faith and kept a positive outlook. She tried to control what she could. And, critically, she received biomarker testing.
The EPIC Act would encourage investment in clinical trials for additional uses of existing drugs.